ALLPACK Indonesia 2026 has concluded. At the exhibition, Suzhou Singmed Medical Device Science and Technology Ltd. (Singmed) showcased its technical expertise and manufacturing capabilities in advanced pharmaceutical packaging, drug delivery systems, and wearable medical devices. The event provided an international platform for industry engagement and an opportunity to explore collaboration across Southeast Asia.
1. Advancing Pharmaceutical Packaging Through Precision Manufacturing
As the pharmaceutical industry places increasing emphasis on packaging safety, product quality, and manufacturing efficiency, Singmed is further developing its advanced pharmaceutical packaging portfolio and manufacturing capabilities. With capabilities spanning product structural design, materials engineering, precision tooling, injection molding, and automated production, the company is committed to providing reliable product development and manufacturing support.
From product design to process optimization, Singmed closely integrates R&D and manufacturing, applying precision engineering to ensure product quality, production efficiency, and commercial-scale manufacturing.
2. Driving Innovation in Pulmonary and Nasal Drug Delivery
Drug delivery devices play a critical role in linking pharmaceutical formulations, device performance, and the patient experience. Focusing on oral inhalation and nasal drug delivery, Singmed is advancing its technology platforms for dry powder inhalers (DPIs), soft mist inhalers (SMIs), and nasal drug delivery systems.
The company is building its R&D and engineering expertise in aerosol performance, device design, delivered dose, and formulation–device compatibility. By integrating product design, performance evaluation, and precision manufacturing, Singmed provides platform-based development support for pharmaceutical and medical device companies.
3. Expanding Wearable Medical Technologies Across Diverse Applications
Beyond drug delivery systems, Singmed develops wearable medical devices and associated precision mechanisms for applications including subcutaneous drug delivery and continuous glucose monitoring (CGM).
In the CGM field, Singmed develops and manufactures sensor applicators and related products. Through precision mechanical design, tooling and injection molding, automated assembly, and quality control, the company is strengthening its capabilities in product engineering and manufacturing scale-up.
Singmed also offers medical device assembly, supported by regulatory affairs expertise and registration support for international markets. Together, these capabilities enable the company to provide integrated solutions spanning product development, engineering implementation, and transfer to manufacturing. Through the coordinated development of its drug delivery and wearable technology platforms, Singmed is expanding the applications of precision medical devices.
4. Based in China, Connecting Globally to Create Value Across the Industry
ALLPACK Indonesia 2026 gave Singmed an opportunity to better understand regional market needs, strengthen international industry engagement, and explore potential partnerships.
Looking ahead, Singmed will remain focused on device innovation, precision engineering, and platform-based R&D, further strengthening its technical and manufacturing capabilities in advanced pharmaceutical packaging, drug delivery systems, and wearable medical devices while expanding its global partnership network.
The exhibition has concluded, but innovation continues.
Singmed looks forward to working with pharmaceutical companies, medical device companies, and partners across the industry value chain worldwide. Drawing on its engineering expertise, the company aims to help bring innovative products into commercial production and to jointly shape the future of drug delivery and wearable medical technologies.
About Singmed：
Singmed combines device innovation and precision engineering to develop and manufacture drug delivery systems, drug-device combination products and wearable medical devices, supported by in-house capabilities in regulatory affairs and registration submissions for international markets. The company focuses on four application areas: oral inhalation, nasal delivery, wearable subcutaneous delivery, and continuous glucose monitoring (CGM), including sensor applicators and related devices. Its manufacturing capabilities also include active medical device assembly.
Contacts：
Media Inquiries: [email protected]
Business Inquiries: [email protected]
Organization: Suzhou Singmed Medical Device Science and Technology Ltd.
Website: https://www.singmed.cn/